Anda di halaman 1dari 8

GENERIC NAME

BRAND NAME

DOSAGE/ FREQUENCY/ ROUTE 50 mg QID 1 tab PO

CLASSIFIC ATION

ACTION

INDICATION

SIDE EFFECTS

CONTRAINDICATIO N

Tramadol

Analgrsic

Treat moderate to severe pain

Moderate to moderately severe pain

Health professionals have-not yet fully endorsed of its use on a large scale for these disorders, although it may be used when other treatments have failed (under the supervision of psychiatrist).

NURSI NG RESPO NSIBIL TY Should the check the patients name, the correct route, dosage, and frequen cy of the medicin e that should be given

GENERIC NAME

BRAND NAME

Captopril

Capoten

DOSAG E/ FREQU ENCY/ ROUTE 25 mg 1 tab/ SL

CLASSIFICATI ON

ACTION

INDICATIO N

SIDE EFFECTS

CONTRAINDICATIO N

NURSING RESPONSIBILTY

Angiotensin Converting Enzyme (ACE) Inhibitor, Antihypertensi ve

Captopril (Capoten) is an angiotension converting enzyme inhibitor. An AngiotensinConverting Enzyme converts angiotensin I to angiotensin II. Angiotensin II is a potent endogenous vasoconstrictor substance.

Hypertensio n

1. Dizziness or lightheadednes s 2. Fatigue 3. Headache 4. Insomnia 5. Weakness or excessive tiredness 6. Cough 7. Hypotension 8. Tachycardia or fast heartbeat 9. Taste disturbances: salty or metallic taste or

1. Hypersensitivit y 2. Cross sensitivity among Ace inhibitors 3. Pregnancy 4. Angioedema (hereditary or idiopathic)

1. Monitor blood pressure and pulse frequently during initial dose adjustment and periodically during therapy. (for patients treated with hypertension) 2.For patients treated with CHF, monitor

decreased ability to taste 10. ea Diarrh

weight and assess patient routinely for resolution of fluid overload. Sign s of fluid overload are: peripheral edema, rales or crackles, dyspnea, weight gain and jugular vein distention.

GENERIC NAME

BRAND NAME

Captopril

Capoten

DOSAG E/ FREQU ENCY/ ROUTE 25 mg 1 tab/ SL

CLASSIFICATI ON

ACTION

INDICATIO N

SIDE EFFECTS

CONTRAINDICATIO N

NURSING RESPONSIBILTY

Angiotensin Converting Enzyme (ACE) Inhibitor, Antihypertensi ve

Captopril (Capoten) is an angiotension converting enzyme inhibitor. An AngiotensinConverting Enzyme converts angiotensin I to angiotensin II. Angiotensin II is a potent endogenous vasoconstrictor substance.

Hypertensio n

11. ess or

Dizzin

5. Hypersensitivit y 6. Cross sensitivity among

3. Monitor blood pressure and pulse frequently during initial dose adjustment and periodically

lightheadednes s 12. e 13. ache 14. nia 15. ness or excessive tiredness 16. h Coug Weak Insom Head Fatigu

Ace inhibitors 7. Pregnancy 8. Angioedema (hereditary or idiopathic)

during therapy. (for patients treated with hypertension) 4.For patients

17. ension 18.

Hypot

treated with CHF, monitor

Tachy

weight and assess patient routinely for

cardia or fast heartbeat 19. Taste

resolution of fluid overload. Sign s of fluid overload are: peripheral edema, rales or crackles, dyspnea, weight gain and jugular vein distention.

disturbances: salty or metallic taste or decreased ability to taste 20. ea Diarrh

GENERIC NAME

BRAND NAME

Senokot Forte

Sennosides

DOSAG E/ FREQU ENCY/ ROUTE 2 tabs OD

CLASSIFICATI ON

ACTION

INDICATIO N

SIDE EFFECTS

CONTRAINDICATIO N

NURSING RESPONSIBILTY

Laxative

Active components of senna (sennosides) alter water and electrolyte transport in the large intestine, resulting in accumulation of water and increased peristalsis.

Constipatio n

GI: cramping, diarrhea, nausea GU: pink-red or brown-black discoloration of urine F & E: electrolyte abnormalities

Hypersensitivity you have had recent abdominal surgery or require immediate abdominal surgery you have appendicitis; bleeding of the stomach, intestine, or rectum; or an obstruction in your intestines (fecal impaction)

Asses patient for abdominal distention, presence of bowel sounds, and usual pattern of bowel function. 2. Assess for color, consistency, and amount of stool produced. 3. Take with full glass of water.

Ideally, administer at bedtime for evacuation 6-12 hours later. Administer on an empty stomach for a rapid result. 4. Advise patient that laxatives should be used only for short-term therapy. Long-term therapy may cause electrolyte imbalance and

dependence, 5. Encourage patient to use other forms of bowel regulation such as increasing bulk in the diet, increasing fluid intake, and increasing mobility